Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-07-31FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for pramipexole dihydrochloride from Macleods Pharmaceuticals Limited. This action updates the p…
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: Phase I Deep Brain Stimulation (DBS) vs. Best Medical Therapy (BMT) Trial [Phase 3]
This update reports the completion of a Phase 3 trial comparing deep brain stimulation to best medical therapy in Parkinson's disease, with …
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: An Extension of Istradefylline in North American Parkinson's Disease Patients Who Have Completed Study 6002-INT-001 [Phase 3]
Phase 3 extension trial of istradefylline in North American Parkinson's disease patients who completed a prior study was terminated; results…
-
CLINICAL_TRIALS trial_result · 2013-07-19Clinical Trial Update: A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease [Phase 2]
A Phase 2 clinical trial evaluating the safety and tolerability of oral AZD3241 in patients with Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-12Clinical Trial Update: The Effects of Vitamin D and Bone Loss in Parkinson's Disease [Phase 2]
A Phase 2 completed trial evaluating whether vitamin D supplementation reduces bone loss in people with Parkinson's disease.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Effects of High-dose Coenzyme Q10 on Biomarkers of Oxidative Damage and Clinical Outcome in Parkinson Disease [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluated high-dose Coenzyme Q10 for effects on oxidative damage biomarkers and clinical outcomes in Pa…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Executive, Activities of Daily Living, and Cholinergic Functions in Parkinson's Disease
Completed University of Michigan trial in Parkinson's disease reporting results related to executive function, activities of daily living, a…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Evaluation of the Effect of Repetitive Transcranial Magnetic Stimulation in Pain Perception in Parkinson's Disease [Phase 2]
A Phase 2 clinical trial evaluating the effect of repetitive transcranial magnetic stimulation on pain perception in Parkinson's disease has…
-
CLINICAL_TRIALS research · 2013-06-17Clinical Trial Update: Study of Sexuality in Parkinson Disease
A completed clinical trial investigating sexuality in people with Parkinson disease.
-
FDA label_change · 2013-06-12FDA Approved: CYCLOSET — Supplemental Application (Avvisto Therapeutics LLC)
The FDA approved a supplemental application for CYCLOSET (bromocriptine mesylate) submitted by Avvisto Therapeutics LLC. The action involves…
-
CLINICAL_TRIALS trial_result · 2013-06-12Clinical Trial Update: Phase IV Study to Evaluate the Efficacy and Safety of Mircera in PD [Phase 4]
This is a Phase IV clinical trial evaluating the efficacy and safety of Mircera in Parkinson disease. The sponsor is Samsung Medical Center,…
-
CLINICAL_TRIALS trial_result · 2013-06-11Clinical Trial Update: Study of KW-6002 (Istradefylline) in Parkinson's Disease in Patients With Motor Response Complications on Levodopa [Phase 3]
This clinical trial update notes that a Phase 3 study of KW-6002 (istradefylline) in Parkinson's disease patients with motor fluctuations on…
-
CLINICAL_TRIALS trial_result · 2013-05-31Clinical Trial Update: Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of Eszopiclone [Phase 3]
Phase 3, multi-site, placebo-controlled trial evaluating eszopiclone for insomnia in patients with Parkinson's disease; results were posted …
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Increased Gut Permeability to Lipopolysaccharides (LPS) in Parkinson's Disease
A completed Rush University Medical Center clinical trial investigates increased gut permeability to lipopolysaccharides in Parkinson's dise…
-
CLINICAL_TRIALS trial_result · 2013-05-20Clinical Trial Update: Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment [Phase 4]
Phase 4 clinical trial to assess safety and efficacy of Tigan for preventing nausea and vomiting during initiation and treatment with Apokyn…
-
CLINICAL_TRIALS trial_result · 2013-05-17Clinical Trial Update: Neuroimaging Studies of Depression in Parkinson's Disease
An update on a completed trial investigating neuroimaging findings related to depression in Parkinson's disease.
-
CLINICAL_TRIALS research · 2013-05-14Clinical Trial Update: Nicotine Treatment of Impulsivity in Parkinson's Disease [Phase 4]
Phase 4 clinical trial evaluating nicotine treatment for impulsivity in Parkinson's disease; current status is unknown.
-
FDA approval · 2013-05-13FDA Approved: TRIHEXYPHENIDYL HYDROCHLORIDE — Supplemental Application (Akorn)
FDA approved a supplemental application for Akorn's Trihexyphenidyl hydrochloride.
-
CLINICAL_TRIALS trial_result · 2013-05-13Clinical Trial Update: Phase I/II Study of the Safety, Efficacy and Dose Evaluation of ProSavin for the Treatment of Bilateral Idiopathic Parkinson's Disease [Phase 1, Phase 2]
Phase 1/2 trial evaluating the safety, efficacy, and dose evaluation of ProSavin for bilateral idiopathic Parkinson's disease has completed.
-
FDA approval · 2013-05-11FDA Approved: TASMAR — Supplemental Application (Bausch Health US LLC)
FDA approves a supplemental application for TASMAR (tolcapone) submitted by Bausch Health US LLC.
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: Behavioral Treatments for Anxiety and Depression in Veterans With Parkinson's Disease [Phase 1, Phase 2]
Completed Phase 1/Phase 2 clinical trials evaluating behavioral treatments for anxiety and depression in veterans with Parkinson disease.
-
FDA approval · 2013-04-30FDA Approved: TASMAR — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for TASMAR (tolcapone) filed by Bausch Health US LLC.
-
CLINICAL_TRIALS research · 2013-04-24Clinical Trial Update: Pedunculo-Pontin Nucleus (PPN) - Deep Brain Stimulation (DBS) in Gait and Balance Disturbance in Parkinson's Disease (PPN-GAB-PARK Study) [Phase 1, Phase 2]
Phase 1/2 clinical trial update on pedunculopontine nucleus deep brain stimulation for gait and balance disturbances in Parkinson disease, s…
-
FDA approval · 2013-04-22FDA Approved: ROPINIROLE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original application for a generic ropinirole product.
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease [Phase 2]
This clinical trial update reports the safety, tolerability, and preliminary efficacy results from a Phase 2 study of Dynacirc CR in Parkins…